Comment on AHA Scientific Statement `Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation”

Q4 Medicine
B. Todurov
{"title":"Comment on AHA Scientific Statement `Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation”","authors":"B. Todurov","doi":"10.24969/hvt.2023.414","DOIUrl":null,"url":null,"abstract":"Recently published AHA Scientific Statement document “Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement from the American Heart Association” has a detailed analysis of simultaneous heart transplantation along with kidney and liver transplantation (1). The combination of cardiac, renal and hepatic insufficiencies is quite common and is a challenge for transplant teams in all transplantation centers. The protocols and guidelines for transplantation of each individual organ are now well developed, but the indications and risk factors in simultaneous transplantations are always very personalized and difficult to systematize and summarize. In this article, the authors have managed to make a statistical analysis of the indications for surgery, analyze immune responses after dual-organ transplantation, compare different immunosuppression protocols, describe various techniques of simultaneous transplantation, and track immediate and long-term outcomes, all using a large clinical material. Based on this profound analysis, the authors make recommendations for a protocol of pre-surgery evaluation. Following the evaluation results, clear indications for heart-kidney and heart-liver transplantation are defined. Recommendations for induction and long-term immunosuppression are given. The authors also analyze organ allocation policies and the risks for unfair allocation, especially for kidney transplant candidates where the gap between the number of recipients and the number of transplantations is particularly large. Such allocation should be based on ethical principles of fairness and rational use of donor organs. Of particular interest in the article is Table 2, which shows unresolved issues and potential solutions of dualorgan transplantation. The lack of consensus for selection of patients for dual-organ transplantation remains an open issue and requires further resolution. Summarizing their study, the authors conclude that in the context of organ donor shortage, a very balanced selection of candidates for dual heart-kidney and heartliver transplantation should be made, keeping in mind that two recipients, each in need of only one organ, can be saved with these two organs. The article authors have certainly done a great analytical job in such a complex problem. The published results are especially helpful to those centers that are just starting their transplant program and have no experience of their own in dual-organ transplantations.","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Vessels and Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24969/hvt.2023.414","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Recently published AHA Scientific Statement document “Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement from the American Heart Association” has a detailed analysis of simultaneous heart transplantation along with kidney and liver transplantation (1). The combination of cardiac, renal and hepatic insufficiencies is quite common and is a challenge for transplant teams in all transplantation centers. The protocols and guidelines for transplantation of each individual organ are now well developed, but the indications and risk factors in simultaneous transplantations are always very personalized and difficult to systematize and summarize. In this article, the authors have managed to make a statistical analysis of the indications for surgery, analyze immune responses after dual-organ transplantation, compare different immunosuppression protocols, describe various techniques of simultaneous transplantation, and track immediate and long-term outcomes, all using a large clinical material. Based on this profound analysis, the authors make recommendations for a protocol of pre-surgery evaluation. Following the evaluation results, clear indications for heart-kidney and heart-liver transplantation are defined. Recommendations for induction and long-term immunosuppression are given. The authors also analyze organ allocation policies and the risks for unfair allocation, especially for kidney transplant candidates where the gap between the number of recipients and the number of transplantations is particularly large. Such allocation should be based on ethical principles of fairness and rational use of donor organs. Of particular interest in the article is Table 2, which shows unresolved issues and potential solutions of dualorgan transplantation. The lack of consensus for selection of patients for dual-organ transplantation remains an open issue and requires further resolution. Summarizing their study, the authors conclude that in the context of organ donor shortage, a very balanced selection of candidates for dual heart-kidney and heartliver transplantation should be made, keeping in mind that two recipients, each in need of only one organ, can be saved with these two organs. The article authors have certainly done a great analytical job in such a complex problem. The published results are especially helpful to those centers that are just starting their transplant program and have no experience of their own in dual-organ transplantations.
美国心脏协会科学声明《双器官移植:心肾和心肝移植的适应症、评价和结果》评论
最近发表的AHA科学声明文件“双器官移植:心脏-肾脏和心脏-肝脏移植的适应症、评估和结果:美国心脏协会的科学声明”详细分析了同时进行心脏移植和肾脏和肝脏移植的情况(1)。心脏、肾脏和肝脏功能不全的合并是相当常见的,是所有移植中心移植团队面临的挑战。目前各器官移植的方案和指南已经较为完善,但同时移植的适应症和危险因素往往非常个性化,难以系统化和总结。在本文中,作者利用大量的临床资料,对手术适应症进行了统计分析,分析了双器官移植后的免疫反应,比较了不同的免疫抑制方案,描述了同时移植的各种技术,并跟踪了近期和长期的结果。基于这一深刻的分析,作者提出了术前评估方案的建议。根据评估结果,明确了心肾、心肝移植的适应症。给出了诱导和长期免疫抑制的建议。作者还分析了器官分配政策和不公平分配的风险,特别是对于肾移植候选人,受者数量和移植数量之间的差距特别大。这种分配应以公平和合理使用捐赠器官的伦理原则为基础。本文特别感兴趣的是表2,它显示了双器官移植尚未解决的问题和潜在的解决方案。双器官移植患者的选择缺乏共识仍然是一个悬而未决的问题,需要进一步解决。总结他们的研究,作者得出结论,在器官供体短缺的背景下,应该对双心肾和双心肝移植的候选人进行非常平衡的选择,记住两个接受者,每个人只需要一个器官,这两个器官可以拯救他们。这篇文章的作者对这样一个复杂的问题确实做了很好的分析工作。发表的结果对那些刚刚开始他们的移植项目并且没有双器官移植经验的中心特别有帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
45
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信